UOC Radiologia, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122, Milan, Italy.
UOC Radiologia Diagnostica ed Interventistica, ASST Settelaghi, Insubria University, Varese, Italy.
Cardiovasc Intervent Radiol. 2023 Jul;46(7):827-834. doi: 10.1007/s00270-023-03463-5. Epub 2023 May 24.
The aim of this prospective, multicentre, observational study was to compare the efficacy and safety of balloon-based and non-balloon-based vascular closure devices (VCDs).
From March 2021 to May 2022, 2373 participants from 10 different centres were enrolled. Among them, 1672 patients with 5-7 Fr accesses were selected. Successful haemostasis, failure and safety were evaluated. Successful haemostasis was defined as the possibility to obtain complete haemostasis with the use of VCDs, without any complication. Failure management was defined as the need of manual compression. Safety was defined as the rate of complications. Cases of haematomas/pseudoaneurysms (PSA) and artero-venous fistula (AVF) were collected.
VCDs mechanism of action is statistically significant associated with the outcome. Non-balloon-based VCDs demonstrated a statistically significant better outcome: successful haemostasis was obtained in 96.5% vs. 85.9%, of cases when compared to balloon occluders (p < 0.001). The incidence of AVF was statistically more frequent using non-balloon occluders devices (1.57% vs 0%, p: 0.007). No significant statistical difference was found in comparing haematoma and PSA occurrence. Thrombocytopenia, coagulation deficit, BMI, diabetes mellitus and anti-coagulation were demonstrated to be independent predictors of failure management.
Our study suggests a better outcome with the same complication rate, except that for AVF incidence for non-balloon collagen plug device if compared to balloon occluders vascular closure devices.
本前瞻性、多中心、观察性研究旨在比较基于球囊和非基于球囊的血管闭合装置(VCD)的疗效和安全性。
2021 年 3 月至 2022 年 5 月,来自 10 个不同中心的 2373 名参与者入组。其中,选择了 1672 名 5-7Fr 入路的患者。评估了成功止血、失败和安全性。成功止血定义为使用 VCD 获得完全止血且无任何并发症的可能性。失败管理定义为需要手动压迫。安全性定义为并发症发生率。收集血肿/假性动脉瘤(PSA)和动静脉瘘(AVF)的病例。
VCD 的作用机制与结果具有统计学意义的相关性。非球囊 VCD 的结果明显更好:与球囊闭塞器相比,成功止血率为 96.5%比 85.9%(p<0.001)。使用非球囊闭塞器时,AVF 的发生率具有统计学意义更高(1.57%比 0%,p:0.007)。比较血肿和 PSA 发生时,未发现统计学差异。血小板减少症、凝血缺陷、BMI、糖尿病和抗凝被证明是失败管理的独立预测因素。
我们的研究表明,在具有相同并发症发生率的情况下,非球囊胶原蛋白塞装置的结果更好,除非与球囊闭塞器相比,非球囊 VCD 的 AVF 发生率更高。